Pathos
Pathos is at the forefront of a novel approach to AI-driven drug development. This approach harnesses multimodal data, cutting-edge Artificial Intelligence, and profound clinical understanding to expedite the introduction of new therapies for patients. With an emphasis on Artificial Intelligence, clinical development, and implementation, Pathos is dedicated to enhancing patient outcomes by speeding up the transition from molecule to medicine.
Funding
Every round, secondary, debt facility or acquisition involving Pathos that AI Lounge tracks, newest first.
No rounds recorded yet.
Members see every AI company on AI Lounge with revenue, funding, valuation and investors, searchable and sortable, free.
Create my free account →Log in